Inspire Medical Systems had its Relative Strength (RS) Rating upgraded from 67 to 79 Thursday — a welcome improvement, but still shy of the 80 or better score you look for.
This exclusive rating from Investor's Business Daily identifies share price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating as they begin their largest price moves. See if Inspire Medical Systems can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Inspire Medical Systems is trying to complete a consolidation with a 225.00 buy point. See if it can break out in volume at least 40% higher than normal.
Inspire Medical Systems posted 0% EPS growth in the latest quarterly report. Revenue increased 33%.
Inspire Medical Systems earns the No. 13 rank among its peers in the Medical-Products industry group. LeMaitre Vascular, Globus Medical and Pro-Dex are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
